Parkinson's Disease Epidemiology Insights to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Parkinson's Disease - Epidemiology Insights to 2025" report has been added to ResearchAndMarkets.com's offering.

Parkinson's Disease - Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Parkinson's Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data. The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.

Key Coverage and Benefits:

  • The report includes the prevalent population and how will it change over the next eight years.
  • Coverage of key Parkinson's Disease sub-populations and its prevalent or incident cases
  • Prevalent or incident cases segmented by age and sex.
  • The key differences in epidemiology patterns across the seven market segments.

Key Topics Covered:

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary

4. Parkinson's Disease Overview

5. Risk Factors Associated with Parkinson's Disease

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations

8. Prevalent & Incident Cases by 7 MM-2015-2025

9. Key Takeaways

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/9vv8c5/parkinsons?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs